Free Trial

Verastem (VSTM) Financials

Verastem logo
$8.01 -0.17 (-2.05%)
As of 10:22 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Verastem

Annual Income Statements for Verastem

This table shows Verastem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Consolidated Net Income / (Loss)
-58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Net Income / (Loss) Continuing Operations
-58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Total Pre-Tax Income
-58 -36 -68 -72 -149 -68 -71 -74 -87 -130 -209
Total Operating Income
-58 -37 -68 -95 -132 -49 -61 -73 -92 -115 -170
Total Gross Profit
0.00 0.00 0.00 27 16 87 2.05 2.60 0.00 10 26
Total Revenue
0.00 0.00 0.00 27 17 89 2.05 2.60 0.00 10 31
Operating Revenue
- 0.00 - 27 17 89 2.05 2.60 0.00 10 31
Total Cost of Revenue
0.00 0.00 0.00 0.17 1.24 1.77 0.00 0.00 0.00 0.00 4.60
Operating Cost of Revenue
- 0.00 - 0.17 1.24 1.77 - - 0.00 0.00 4.60
Total Operating Expenses
58 37 68 121 149 136 63 76 92 125 196
Selling, General & Admin Expense
18 17 21 77 101 63 24 25 31 44 81
Research & Development Expense
41 20 46 44 46 41 39 51 61 81 115
Amortization Expense
- 0.00 - 0.42 1.57 0.79 - - 0.00 0.00 0.70
Total Other Income / (Expense), net
0.33 0.56 0.00 22 -17 -18 -9.79 -0.88 4.72 -15 -39
Interest Expense
0.00 0.00 0.56 5.81 21 17 9.97 2.14 4.14 4.56 2.96
Interest & Investment Income
0.33 0.56 0.56 2.60 4.38 0.52 0.18 1.22 6.21 4.15 4.07
Other Income / (Expense), net
- - - 26 -0.64 -1.31 0.00 0.05 2.64 -15 -40
Income Tax Expense
- - - 0.00 0.00 0.19 - 0.00 0.00 0.19 0.00
Basic Earnings per Share
($1.61) ($0.99) ($1.76) ($1.12) ($2.00) ($0.44) ($4.90) ($4.57) ($3.96) ($3.66) ($3.02)
Weighted Average Basic Shares Outstanding
35.93M 36.99M 38.42M 64.96M 74.58M 153.33M 14.54M 16.14M 22.05M 35.71M 69.31M
Diluted Earnings per Share
($1.61) ($0.99) ($1.76) ($1.37) ($2.00) ($0.44) ($4.90) ($4.57) ($3.96) ($3.66) ($3.02)
Weighted Average Diluted Shares Outstanding
35.93M 36.99M 38.42M 69.32M 74.58M 153.33M 14.54M 16.14M 22.05M 35.71M 69.31M
Weighted Average Basic & Diluted Shares Outstanding
35.93M 36.99M 38.50M 64.70M 148.41M 171.67M 186.33M 200.68M 25.30M 51.49M 87.84M

Quarterly Income Statements for Verastem

This table shows Verastem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-34 -8.26 -24 -65 -52 -26 -99 -33 -37 -35 -75
Consolidated Net Income / (Loss)
-34 -8.26 -24 -65 -52 -26 -99 -33 -37 -35 -75
Net Income / (Loss) Continuing Operations
-28 -8.26 -24 -71 -52 -26 -99 -33 -37 -35 -75
Total Pre-Tax Income
0.00 0.00 0.00 -130 -52 -26 -99 -209 -37 -34 -75
Total Operating Income
-28 -18 -37 -32 -44 -44 -41 -41 -45 -33 -75
Total Gross Profit
0.00 10 0.00 - 0.00 1.82 9.57 15 16 36 20
Total Revenue
0.00 10 0.00 - 0.00 2.14 11 18 19 40 24
Operating Revenue
- 10 0.00 - 0.00 2.14 11 - 19 40 24
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.32 1.67 2.61 2.77 3.76 3.67
Operating Cost of Revenue
- 0.00 0.00 - 0.00 0.32 1.67 - 2.77 3.76 3.67
Total Operating Expenses
28 28 37 32 44 46 50 56 61 69 96
Selling, General & Admin Expense
10 10 12 11 15 21 21 24 22 27 26
Research & Development Expense
18 18 25 21 29 25 29 32 38 41 69
Amortization Expense
- 0.00 0.00 - 0.00 0.13 0.29 - 0.28 0.28 0.28
Total Other Income / (Expense), net
0.21 10 13 -39 -7.89 18 -58 8.56 8.31 -1.15 0.50
Interest Expense
1.13 1.14 1.15 1.15 2.02 0.21 0.32 0.42 0.38 0.36 0.21
Interest & Investment Income
1.37 0.98 0.83 0.97 0.96 0.82 1.18 1.10 1.30 1.11 0.77
Other Income / (Expense), net
-0.03 10 13 -39 -6.83 17 -59 7.87 7.39 -1.90 -0.05
Income Tax Expense
- - - - - 0.00 0.00 - - 0.82 0.00
Basic Earnings per Share
($1.26) ($0.31) ($0.60) ($1.81) ($0.96) ($0.39) ($1.35) ($0.32) ($0.37) ($0.35) ($0.74)
Weighted Average Basic Shares Outstanding
26.83M 26.86M 40.26M 35.71M 54.17M 66.14M 73.16M 69.31M 98.29M 100.12M 101.24M
Diluted Earnings per Share
($1.26) ($0.31) ($0.60) ($1.81) ($0.96) ($0.62) ($1.35) ($0.09) ($0.46) ($0.35) ($0.74)
Weighted Average Diluted Shares Outstanding
26.83M 26.86M 40.26M 35.71M 54.17M 74.04M 73.16M 69.31M 99.15M 100.12M 101.24M
Weighted Average Basic & Diluted Shares Outstanding
40.24M - 44.51M 51.49M 54.95M 61.55M 66.78M 87.84M 87.87M 90.56M 126.01M

Annual Cash Flow Statements for Verastem

This table details how cash moves in and out of Verastem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-9.03 7.44 50 48 -51 -11 -47 54 3.29 9.98 116
Net Cash From Operating Activities
-46 -29 -57 -75 -139 -34 -54 -64 -86 -105 -138
Net Cash From Continuing Operating Activities
-46 -29 -57 -75 -139 -34 -54 -64 -86 -105 -138
Net Income / (Loss) Continuing Operations
-58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Consolidated Net Income / (Loss)
-58 -36 -68 -72 -149 -68 -71 -74 -87 -131 -209
Depreciation Expense
0.75 0.67 0.56 1.00 0.43 0.53 0.21 0.12 0.06 0.03 0.03
Amortization Expense
0.26 -0.14 0.22 2.24 8.88 11 9.20 0.23 -1.13 -0.01 0.73
Non-Cash Adjustments To Reconcile Net Income
10 6.29 5.03 -19 9.18 30 7.71 5.89 2.93 22 45
Changes in Operating Assets and Liabilities, net
1.16 0.14 4.68 14 -7.80 -7.83 0.58 3.90 -0.96 3.92 26
Net Cash From Investing Activities
-27 37 44 -138 90 -47 0.09 66 -44 60 -9.62
Net Cash From Continuing Investing Activities
-27 37 44 -138 90 -47 0.09 66 -44 60 -9.62
Purchase of Property, Plant & Equipment
-0.21 -0.04 - -1.51 -0.01 -0.03 -0.20 0.00 0.00 -0.03 0.00
Acquisitions
- 0.00 - -22 - - - - 0.00 0.00 -9.62
Purchase of Investments
-200 -82 -7.96 -125 -94 -79 -86 -18 -96 0.00 0.00
Sale and/or Maturity of Investments
173 119 52 11 184 32 87 84 52 60 0.00
Net Cash From Financing Activities
64 -0.01 63 261 -2.44 70 6.89 52 134 55 263
Net Cash From Continuing Financing Activities
64 -0.01 63 261 -2.44 70 6.89 52 134 55 263
Repayment of Debt
0.00 0.00 - 0.00 -13 -39 0.00 0.00 -0.30 -0.15 -43
Issuance of Debt
0.00 0.00 15 155 0.57 0.00 0.00 24 15 0.00 75
Issuance of Preferred Equity
- - - - - - 0.00 0.00 28 0.00 0.00
Issuance of Common Equity
64 0.00 48 105 0.00 106 6.72 27 91 54 197
Other Financing Activities, net
-0.40 -0.01 0.44 0.81 9.60 2.70 0.16 0.28 0.06 1.12 34
Cash Interest Paid
0.00 0.00 0.30 2.11 12 5.13 1.01 1.54 3.36 3.77 6.36
Cash Income Taxes Paid
- - - - - - - - 0.00 0.00 0.19

Quarterly Cash Flow Statements for Verastem

This table details how cash moves in and out of Verastem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
3.52 1.02 30 -24 29 47 -27 67 -39 -29 36
Net Cash From Operating Activities
-28 -28 -24 -25 -39 -33 -36 -30 -52 -44 -34
Net Cash From Continuing Operating Activities
-28 -28 -24 -25 -39 -33 -36 -30 -52 -44 -34
Net Income / (Loss) Continuing Operations
-34 -8.26 -24 -65 -52 -26 -99 -33 -37 -35 -75
Consolidated Net Income / (Loss)
-34 -8.26 -24 -65 -52 -26 -99 -33 -37 -35 -75
Amortization Expense
-0.42 0.01 0.20 0.21 0.03 0.13 0.29 0.28 0.16 0.16 0.28
Non-Cash Adjustments To Reconcile Net Income
7.22 -8.94 -11 35 9.12 -15 59 -7.59 -7.12 3.47 1.75
Changes in Operating Assets and Liabilities, net
-1.25 -10 11 4.64 4.27 8.62 2.86 10 -8.57 -13 39
Net Cash From Investing Activities
31 29 - - 0.00 - -8.28 -1.35 -16 16 -7.50
Net Cash From Continuing Investing Activities
31 29 - - 0.00 - -8.28 -1.35 -16 16 -7.50
Net Cash From Financing Activities
0.85 -0.41 54 0.74 67 79 18 99 29 -1.54 78
Net Cash From Continuing Financing Activities
0.85 -0.41 54 0.74 67 79 18 99 29 -1.54 78
Repayment of Debt
0.00 - - - -43 - - 0.00 0.00 -2.50 2.50
Issuance of Debt
0.00 - - - 75 - - - 0.00 - 50
Issuance of Common Equity
0.00 - 14 - 30 70 - 97 0.00 - 29
Other Financing Activities, net
0.85 -0.41 39 0.74 4.85 9.48 18 1.70 29 0.96 -3.76

Annual Balance Sheets for Verastem

This table presents Verastem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
113 84 90 277 145 154 109 95 150 102 246
Total Current Assets
111 81 88 253 85 145 106 93 144 95 223
Cash & Equivalents
25 32 82 130 44 68 21 75 78 89 205
Accounts Receivable
- - 0.00 0.31 2.52 0.24 0.52 0.03 - 0.00 8.81
Inventories, net
- - 0.00 0.33 3.10 - - - - 0.00 1.83
Prepaid Expenses
0.59 0.40 1.12 2.97 3.84 3.47 4.97 4.95 6.55 5.94 7.58
Other Current Assets
- - - - - - - - 0.00 0.20 0.20
Plant, Property, & Equipment, net
2.05 1.42 0.86 1.37 0.95 0.42 0.21 0.09 0.04 0.03 0.00
Total Noncurrent Assets
0.20 0.92 1.14 23 59 9.00 2.71 2.09 6.00 6.55 23
Intangible Assets
- - 0.00 22 20 - - - - 0.00 16
Other Noncurrent Operating Assets
0.00 0.76 1.14 0.79 3.89 2.76 2.47 1.85 5.76 6.30 6.60
Other Noncurrent Nonoperating Assets
0.20 0.16 - 0.24 35 0.24 0.24 0.24 0.24 0.24 0.00
Total Liabilities & Shareholders' Equity
113 84 90 277 145 154 109 95 150 102 246
Total Liabilities
11 11 32 153 138 39 21 48 71 130 189
Total Current Liabilities
10 11 17 37 30 17 19 22 26 31 72
Short-Term Debt
- - - 5.72 - - 0.00 - - - 0.00
Accounts Payable
3.94 4.10 9.19 10 9.66 1.88 2.30 4.90 7.18 4.03 12
Accrued Expenses
6.10 6.90 7.94 21 19 15 16 15 18 26 54
Other Current Liabilities
- - - - 0.87 0.56 0.67 0.79 0.94 1.00 5.84
Total Noncurrent Liabilities
0.52 0.34 15 116 108 22 2.51 26 45 99 117
Long-Term Debt
- 0.00 15 115 104 19 0.25 25 40 41 76
Other Noncurrent Operating Liabilities
0.52 0.34 0.15 1.12 4.36 2.93 2.26 1.47 4.72 59 41
Total Equity & Noncontrolling Interests
102 72 58 124 7.17 115 88 47 57 -29 57
Total Preferred & Common Equity
102 72 58 124 7.17 115 88 47 57 -29 57
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Total Common Equity
102 72 58 124 7.17 115 88 47 57 -29 57
Common Stock
301 308 361 500 532 708 751 785 882 927 1,217
Retained Earnings
-199 -235 -303 -376 -525 -593 -664 -738 -825 -956 -1,165
Accumulated Other Comprehensive Income / (Loss)
0.04 0.03 -0.00 0.13 0.01 0.05 0.03 0.00 0.01 0.00 5.23

Quarterly Balance Sheets for Verastem

This table presents Verastem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
176 106 126 132 196 177 228 207 230
Total Current Assets
174 100 121 125 174 154 203 176 199
Cash & Equivalents
95 83 113 118 164 138 166 136 173
Accounts Receivable
0.00 10 - - 2.08 6.72 10 29 9.87
Inventories, net
- - - - 1.17 1.79 2.29 2.40 2.25
Prepaid Expenses
8.82 5.45 7.29 6.93 6.51 7.64 8.58 8.33 14
Other Current Assets
- 0.83 0.20 0.20 0.20 0.20 0.20 0.20 0.20
Plant, Property, & Equipment, net
0.04 0.05 0.04 0.02 0.02 0.02 0.00 0.00 0.00
Total Noncurrent Assets
1.63 6.06 5.68 6.98 22 23 25 30 30
Intangible Assets
- - - - 16 17 16 16 16
Other Noncurrent Operating Assets
1.39 5.81 5.68 6.74 6.33 6.07 8.52 14 14
Other Noncurrent Nonoperating Assets
0.24 0.24 0.00 0.24 0.00 0.00 0.24 0.24 0.24
Total Liabilities & Shareholders' Equity
176 106 126 132 196 177 228 207 230
Total Liabilities
72 66 94 164 160 192 146 157 220
Total Current Liabilities
24 30 37 36 50 60 67 78 103
Short-Term Debt
0.44 5.45 10 2.01 3.13 0.19 5.80 5.44 6.39
Accounts Payable
5.12 6.68 4.44 7.20 8.05 9.89 9.60 18 20
Accrued Expenses
16 17 22 25 38 45 51 54 71
Other Current Liabilities
0.90 1.02 0.78 1.02 1.04 4.92 0.49 0.49 5.96
Total Noncurrent Liabilities
48 35 57 129 110 133 79 78 116
Long-Term Debt
40 35 31 71 74 78 73 74 113
Other Noncurrent Operating Liabilities
8.09 0.00 26 57 36 55 6.07 4.62 3.17
Total Equity & Noncontrolling Interests
83 19 11 -32 36 -16 82 50 10
Total Preferred & Common Equity
83 19 11 -32 36 -16 82 50 10
Preferred Stock
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
83 19 11 -32 36 -16 82 50 10
Common Stock
881 886 902 969 1,064 1,114 1,275 1,278 1,311
Retained Earnings
-798 -867 -891 -1,008 -1,034 -1,132 -1,202 -1,236 -1,311
Accumulated Other Comprehensive Income / (Loss)
0.05 0.00 0.00 6.64 5.29 2.55 8.62 8.04 10

Annual Metrics And Ratios for Verastem

This table displays calculated financial ratios and metrics derived from Verastem's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
36,934,804.00 36,992,418.00 40,489,396.00 73,740,167.00 74,349,659.00 169,774,432.00 182,185,991.00 210,090,850.00 25,267,436.00 - 66,776,006.00
DEI Adjusted Shares Outstanding
3,077,900.00 3,082,702.00 3,374,116.00 6,145,014.00 6,195,805.00 14,147,869.00 15,182,166.00 17,507,571.00 25,267,436.00 - 66,776,006.00
DEI Earnings Per Adjusted Shares Outstanding
-18.80 -11.82 -20.09 -11.79 -24.08 -4.79 -4.69 -4.22 -3.46 - -3.14
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% -34.67% 407.08% -97.68% 26.45% -100.00% 0.00% 209.14%
EBITDA Growth
-8.11% 36.22% -83.77% 1.54% -87.40% 68.38% -33.01% -39.49% -24.77% -43.65% -61.38%
EBIT Growth
-8.57% 36.42% -83.24% -2.10% -92.10% 61.89% -21.19% -18.70% -22.71% -45.39% -61.93%
NOPAT Growth
-8.57% 36.42% -83.24% -39.79% -39.63% 62.70% -24.41% -18.77% -26.25% -24.84% -47.99%
Net Income Growth
-8.43% 37.03% -86.06% -6.83% -105.99% 54.61% -5.13% -3.67% -18.36% -49.53% -60.35%
EPS Growth
22.22% 38.51% -77.78% 22.16% -45.99% 78.00% -5.13% -3.67% 13.35% 7.58% 17.49%
Operating Cash Flow Growth
-23.46% 35.28% -94.38% -30.02% -85.89% 75.81% -59.68% -19.01% -35.79% -21.18% -31.25%
Free Cash Flow Firm Growth
7.18% 31.82% -67.38% -79.17% -29.81% 78.16% -103.30% -10.06% -28.97% 64.33% -467.73%
Invested Capital Growth
-94.36% -9.63% -61.61% 63.69% 100.97% -26,374.00% 3.41% -25.64% -17.61% -311.86% 7.46%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 4.74% 15.99% -3.40% 103.67% -37.40% 0.00% 0.00% 131.06%
EBITDA Q/Q Growth
3.43% 0.21% -10.24% 14.45% 1.25% 24.39% -0.63% -0.33% -15.83% 0.00% 14.88%
EBIT Q/Q Growth
3.38% 0.43% -10.16% 11.90% 0.25% 23.10% 0.39% -0.47% -14.83% 0.00% 14.81%
NOPAT Q/Q Growth
3.38% 0.43% -10.16% -20.63% 0.73% 25.10% 0.39% -0.46% -18.37% 0.00% -6.17%
Net Income Q/Q Growth
3.48% 0.57% -10.75% 8.68% -22.52% 21.83% 4.54% -0.45% -13.75% 0.00% 13.12%
EPS Q/Q Growth
12.02% -2.06% -6.67% 4.86% -6.95% 13.73% 4.54% -0.45% -37.98% 0.00% 8.48%
Operating Cash Flow Q/Q Growth
-6.90% 12.60% -33.48% 1.51% -14.97% 31.65% 18.03% -11.73% -17.80% 4.19% -3.66%
Free Cash Flow Firm Q/Q Growth
4.47% 15.76% -37.52% -27.95% 5.88% 27.10% 20.74% -14.08% -23.50% 0.00% -60.99%
Invested Capital Q/Q Growth
5.16% -90.15% 17.22% 61.06% 101.94% 32.29% -63.54% 4.40% 11.60% 0.00% 4.61%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 99.38% 92.91% 98.01% 100.00% 100.00% 0.00% 100.00% 85.12%
EBITDA Margin
0.00% 0.00% 0.00% -247.00% -708.48% -44.17% -2,533.17% -2,794.45% 0.00% -1,300.18% -678.72%
Operating Margin
0.00% 0.00% 0.00% -354.75% -758.14% -55.76% -2,991.18% -2,809.59% 0.00% -1,149.56% -550.33%
EBIT Margin
0.00% 0.00% 0.00% -259.10% -761.81% -57.25% -2,991.18% -2,807.78% 0.00% -1,300.39% -681.16%
Profit (Net Income) Margin
0.00% 0.00% 0.00% -271.11% -854.77% -76.51% -3,468.10% -2,843.30% 0.00% -1,306.37% -677.59%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.29% 100.00% 100.00% 100.00% 100.14% 100.00%
Interest Burden Percent
99.43% 98.48% 100.00% 104.63% 112.20% 133.27% 115.94% 101.26% 97.68% 100.32% 99.48%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-60.52% -41.70% -104.33% -79.61% -226.98% -110.62% -70.21% -109.39% -138.76% -526.34% -1,480.15%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% -195,661.40% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% -37.72% -62.98% -33.85% -46.70% -71.56% 0.00% -103.51% -121.03%
Return on Assets (ROA)
0.00% 0.00% 0.00% -39.47% -70.67% -45.24% -54.14% -72.47% 0.00% -103.99% -120.39%
Return on Common Equity (ROCE)
-60.52% -41.70% -104.33% -79.61% -226.98% -110.62% -70.21% -109.39% -115.45% -301.99% -1,480.15%
Return on Equity Simple (ROE_SIMPLE)
-56.47% -50.40% -117.54% -58.27% -2,079.86% -58.75% -81.32% -155.75% 0.00% 452.14% 0.00%
Net Operating Profit after Tax (NOPAT)
-41 -26 -47 -66 -93 -35 -43 -51 -64 -80 -119
NOPAT Margin
0.00% 0.00% 0.00% -248.33% -530.70% -39.03% -2,093.83% -1,966.71% 0.00% -804.69% -385.23%
Net Nonoperating Expense Percent (NNEP)
-16.84% -11.01% -26.60% -6.05% -82.85% -48.95% -24.68% -27.82% -28.53% -68.90% -102.13%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -70.99% -66.14% -680.16% -89.19%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.62% 7.09% 1.99% 0.00% 0.00% 0.00% 0.00% 14.88%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 289.19% 579.81% 70.90% 1,174.62% 962.06% 0.00% 436.22% 262.49%
R&D to Revenue
0.00% 0.00% 0.00% 163.37% 262.25% 46.74% 1,916.56% 1,947.53% 0.00% 813.34% 370.70%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 454.14% 851.05% 153.77% 3,091.18% 2,909.59% 0.00% 1,249.56% 635.45%
Earnings before Interest and Taxes (EBIT)
-58 -37 -68 -69 -133 -51 -61 -73 -89 -130 -211
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-57 -36 -67 -66 -124 -39 -52 -73 -91 -130 -210
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.67 0.57 2.15 1.99 13.89 3.14 4.27 1.78 3.58 0.00 9.01
Price to Tangible Book Value (P/TBV)
0.67 0.57 2.15 2.41 0.00 3.14 4.27 1.78 3.58 0.00 12.64
Price to Revenue (P/Rev)
0.00 0.00 0.00 9.27 5.71 4.09 181.92 32.57 0.00 23.01 16.68
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 2,554.91 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 4.44 7.32 2.64 133.21 8.16 0.00 18.20 12.51
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.26 0.97 14.44 0.17 0.00 0.52 0.51 -1.41 1.33
Long-Term Debt to Equity
0.00 0.00 0.26 0.92 14.44 0.17 0.00 0.52 0.51 -1.41 1.33
Financial Leverage
-1.06 -1.10 -1.18 -1.11 -1.04 -1.11 -1.13 -1.21 -1.28 -2.93 -6.25
Leverage Ratio
1.11 1.13 1.33 2.02 3.21 2.45 1.30 1.51 1.94 5.06 12.29
Compound Leverage Factor
1.10 1.11 1.33 2.11 3.60 3.26 1.50 1.53 1.90 5.08 12.23
Debt to Total Capital
0.00% 0.00% 20.45% 49.21% 93.53% 14.18% 0.28% 34.10% 33.79% 344.21% 57.16%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 2.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 20.45% 46.88% 93.53% 14.18% 0.28% 34.10% 33.79% 344.21% 57.16%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.84% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 79.55% 50.79% 6.47% 85.82% 99.72% 65.90% 48.37% -244.21% 42.84%
Debt to EBITDA
0.00 0.00 -0.22 -1.83 -0.84 -0.49 0.00 -0.34 -0.44 -0.31 -0.36
Net Debt to EBITDA
0.00 0.00 1.07 1.96 -0.23 3.28 1.92 0.87 1.07 0.37 0.61
Long-Term Debt to EBITDA
0.00 0.00 -0.22 -1.74 -0.84 -0.49 0.00 -0.34 -0.44 -0.31 -0.36
Debt to NOPAT
0.00 0.00 -0.31 -1.82 -1.12 -0.55 -0.01 -0.48 -0.62 -0.51 -0.64
Net Debt to NOPAT
0.00 0.00 1.51 1.95 -0.30 3.71 2.33 1.24 1.51 0.60 1.08
Long-Term Debt to NOPAT
0.00 0.00 -0.31 -1.73 -1.12 -0.55 -0.01 -0.48 -0.62 -0.51 -0.64
Altman Z-Score
0.79 -2.20 -3.95 -0.72 -7.08 0.66 1.18 -11.40 -7.01 -15.49 -6.94
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.80% 42.62% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
10.96 7.40 5.13 6.83 2.84 8.48 5.69 4.29 5.45 3.07 3.09
Quick Ratio
10.91 7.36 5.06 6.74 2.61 8.28 5.42 4.06 5.20 2.87 2.96
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-37 -25 -42 -75 -98 -21 -43 -48 -62 -22 -125
Operating Cash Flow to CapEx
-21,591.94% -75,600.00% 0.00% -5,229.12% -1,978,828.57% -101,533.33% -27,296.94% 0.00% 0.00% -374,182.14% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -75.25 -12.97 -4.75 -1.23 -4.36 -22.37 -14.90 -4.82 -42.12
Operating Cash Flow to Interest Expense
0.00 0.00 -102.52 -12.83 -6.72 -1.93 -5.37 -29.80 -20.89 -22.97 -46.39
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 -102.52 -13.07 -6.72 -1.93 -5.38 -29.80 -20.89 -22.97 -46.39
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.15 0.08 0.59 0.02 0.03 0.00 0.08 0.18
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 12.34 64.07 5.44 9.49 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.72 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 23.96 15.07 129.88 6.56 17.19 0.00 289.86 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.02 0.12 0.31 0.00 0.00 0.00 0.00 0.56
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 29.59 5.70 67.12 38.45 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 504.60 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 21,500.71 2,934.74 1,192.20 0.00 0.00 0.00 0.00 653.59
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 -21,500.71 -2,400.55 -1,186.50 67.12 38.45 0.00 0.00 -653.59
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-7.99 -8.76 -14 -5.14 0.05 -13 -13 -16 -19 -77 -71
Invested Capital Turnover
0.00 0.00 0.00 -2.77 -6.86 -13.53 -0.16 -0.18 0.00 -0.21 -0.42
Increase / (Decrease) in Invested Capital
-3.88 -0.77 -5.40 9.02 5.19 -13 0.45 -3.25 -2.81 -58 5.77
Enterprise Value (EV)
-42 -39 52 119 128 233 273 21 130 182 387
Market Capitalization
69 41 124 248 100 362 373 85 206 230 516
Book Value per Share
$2.77 $1.95 $1.42 $1.69 $0.10 $0.68 $0.48 $0.23 $2.27 ($0.65) $0.86
Tangible Book Value per Share
$2.77 $1.95 $1.42 $1.39 ($0.17) $0.68 $0.48 $0.23 $2.27 ($0.65) $0.61
Total Capital
102 72 73 245 111 134 88 72 119 12 134
Total Debt
0.00 0.00 15 120 104 19 0.25 25 40 41 76
Total Long-Term Debt
0.00 0.00 15 115 104 19 0.25 25 40 41 76
Net Debt
-110 -81 -72 -129 28 -128 -100 -63 -97 -48 -129
Capital Expenditures (CapEx)
0.21 0.04 0.00 1.43 0.01 0.03 0.20 0.00 0.00 0.03 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-9.52 -11 -16 -28 -20 -13 -13 -17 -20 -25 -54
Debt-free Net Working Capital (DFNWC)
101 70 71 222 55 128 87 71 117 64 151
Net Working Capital (NWC)
101 70 71 216 55 128 87 71 117 64 151
Net Nonoperating Expense (NNE)
17 11 20 6.09 57 33 28 23 23 50 90
Net Nonoperating Obligations (NNO)
-110 -81 -72 -129 -7.12 -128 -100 -63 -97 -48 -129
Total Depreciation and Amortization (D&A)
1.02 0.53 0.78 3.23 9.31 12 9.40 0.35 -1.07 0.02 0.76
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -103.88% -117.07% -15.12% -638.38% -642.80% 0.00% -248.30% -174.18%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 830.52% 315.48% 144.43% 4,245.01% 2,742.95% 0.00% 639.88% 488.92%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 809.12% 315.48% 144.43% 4,245.01% 2,742.95% 0.00% 639.88% 488.92%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($19.32) ($11.88) ($21.12) ($13.44) ($24.00) $0.00 ($4.92) ($4.56) ($3.96) ($3.66) ($3.02)
Adjusted Weighted Average Basic Shares Outstanding
3.08M 3.08M 4.23M 5.41M 6.21M 0.00 14.53M 16.14M 22.05M 35.71M 69.31M
Adjusted Diluted Earnings per Share
($19.32) ($11.88) ($21.12) ($16.44) ($24.00) $0.00 ($4.92) ($4.56) ($3.93) ($3.66) ($3.02)
Adjusted Weighted Average Diluted Shares Outstanding
3.08M 3.08M 4.23M 5.78M 6.21M 0.00 14.53M 16.14M 22.05M 35.71M 69.31M
Adjusted Basic & Diluted Earnings per Share
($19.32) ($11.88) ($21.12) ($13.44) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.99M 3.08M 3.20M 6.16M 12.37M 0.00 15.53M 16.72M 25.30M 51.49M 87.84M
Normalized Net Operating Profit after Tax (NOPAT)
-41 -26 -47 -66 -93 -35 -43 -51 -64 -80 -119
Normalized NOPAT Margin
0.00% 0.00% 0.00% -248.33% -530.70% -39.03% -2,093.83% -1,966.71% 0.00% -804.69% -385.23%
Pre Tax Income Margin
0.00% 0.00% 0.00% -271.11% -854.77% -76.29% -3,468.10% -2,843.30% 0.00% -1,304.52% -677.59%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 -121.30 -11.92 -6.45 -2.92 -6.16 -34.11 -21.61 -28.50 -71.04
NOPAT to Interest Expense
0.00 0.00 -84.91 -11.42 -4.50 -1.99 -4.31 -23.89 -15.57 -17.64 -40.18
EBIT Less CapEx to Interest Expense
0.00 0.00 -121.30 -12.16 -6.45 -2.92 -6.18 -34.11 -21.61 -28.51 -71.04
NOPAT Less CapEx to Interest Expense
0.00 0.00 -84.91 -11.66 -4.50 -1.99 -4.33 -23.89 -15.57 -17.65 -40.18
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Verastem

This table displays calculated financial ratios and metrics derived from Verastem's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
25,295,495.00 25,325,551.00 40,243,745.00 44,506,526.00 51,486,705.00 54,949,170.00 61,545,270.00 66,776,006.00 87,835,106.00 87,873,639.00 90,563,441.00
DEI Adjusted Shares Outstanding
25,295,495.00 25,325,551.00 40,243,745.00 44,506,526.00 51,486,705.00 54,949,170.00 61,545,270.00 66,776,006.00 87,835,106.00 87,873,639.00 90,563,441.00
DEI Earnings Per Adjusted Shares Outstanding
-1.34 -0.33 -0.60 -1.45 -1.01 -0.47 -1.60 -0.49 -0.42 -0.39 -0.83
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% -78.63% 0.00% 0.00% 0.00% 1,775.43% 113.59%
EBITDA Growth
-46.93% 59.87% -8.15% -139.00% -78.81% -226.58% -322.70% 52.41% 26.72% -30.37% 24.31%
EBIT Growth
-45.16% 60.16% -10.99% -146.75% -81.58% -227.66% -320.22% 52.13% 26.47% -30.37% 24.26%
NOPAT Growth
-45.05% 9.93% -73.78% -1.45% -57.43% -139.45% -9.95% -31.29% -1.64% 25.26% -84.76%
Net Income Growth
-115.50% 66.00% -19.81% -135.86% -53.86% -214.12% -311.06% 49.01% 29.77% -33.70% 24.15%
EPS Growth
-1,475.00% 77.37% 20.00% -45.97% 23.81% -100.00% -125.00% 95.03% 52.08% 43.55% 45.19%
Operating Cash Flow Growth
-39.54% -38.51% -43.44% 15.44% -36.63% -18.47% -52.20% -19.34% -34.75% -34.43% 7.24%
Free Cash Flow Firm Growth
-413.95% -216.45% 34.25% 291.50% 229.42% 161.73% 189.56% -195.69% -301.87% -428.15% -1,475.08%
Invested Capital Growth
83.17% 0.00% -90.02% -311.86% -2,681.05% 0.00% -85.88% 7.46% 72.35% 85.47% 41.92%
Revenue Q/Q Growth
0.00% 0.00% -100.00% 0.00% 0.00% 0.00% 426.06% 55.98% 6.48% 114.65% -40.09%
EBITDA Q/Q Growth
2.66% 71.62% -189.80% -198.55% 27.18% 48.21% -275.10% 66.39% -12.13% 7.78% -117.76%
EBIT Q/Q Growth
1.27% 71.16% -191.94% -196.82% 27.34% 48.00% -274.40% 66.19% -11.61% 7.73% -117.53%
NOPAT Q/Q Growth
9.89% 34.86% -102.60% 14.69% -39.84% 0.93% 6.97% -1.87% -8.25% 27.14% -129.97%
Net Income Q/Q Growth
-23.73% 75.62% -190.30% -169.33% 19.28% 50.23% -279.88% 66.59% -11.16% 5.24% -115.51%
EPS Q/Q Growth
-1.61% 75.40% -93.55% -201.67% 46.96% 35.42% -117.74% 93.33% -411.11% 23.91% -111.43%
Operating Cash Flow Q/Q Growth
4.63% 2.60% 13.69% -5.48% -54.09% 15.55% -10.88% 17.29% -73.99% 15.75% 23.49%
Free Cash Flow Firm Q/Q Growth
-75.27% 1.56% 79.17% 632.73% 18.46% -53.05% -69.77% -669.20% -149.89% 23.68% -26.68%
Invested Capital Q/Q Growth
85.28% 100.00% 0.00% -91.60% 0.61% 33.74% -47.31% 4.61% 70.30% 65.18% -488.62%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 100.00% 0.00% 0.00% 0.00% 85.12% 85.15% 85.10% 85.15% 90.61% 84.73%
EBITDA Margin
0.00% -80.89% 0.00% 0.00% 0.00% -1,236.17% -881.42% -189.95% -200.02% -85.93% -312.33%
Operating Margin
0.00% -182.77% 0.00% 0.00% 0.00% -2,047.92% -362.17% -236.53% -240.46% -81.62% -313.28%
EBIT Margin
0.00% -81.01% 0.00% 0.00% 0.00% -1,242.12% -884.02% -191.65% -200.88% -86.34% -313.49%
Profit (Net Income) Margin
0.00% -82.56% 0.00% 0.00% 0.00% -1,213.57% -876.34% -187.72% -195.98% -86.51% -311.19%
Tax Burden Percent
0.00% 0.00% 0.00% 49.48% 100.08% 0.00% 0.00% 15.71% 100.00% 102.41% 100.00%
Interest Burden Percent
0.00% 0.00% 0.00% 185.83% 102.07% 0.00% 0.00% 623.33% 97.56% 97.84% 99.27%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-224.04% 0.00% -136.87% -526.34% -3,929.71% -461.93% -2,888.71% -1,480.15% -786.15% -471.16% 6,595.50%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% -13.52% -78.01% -34.05% -55.41% -37.53% -154.70%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% -13.21% -77.33% -33.35% -54.06% -37.60% -153.56%
Return on Common Equity (ROCE)
-123.39% 0.00% -94.46% -301.99% 7,044.12% -461.93% 772.84% -1,480.15% -786.15% -471.16% 6,595.50%
Return on Equity Simple (ROE_SIMPLE)
-559.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-20 -13 -26 -22 -31 -31 -29 -29 -31 -23 -53
NOPAT Margin
0.00% -127.94% 0.00% 0.00% 0.00% -1,433.54% -253.52% -165.57% -168.32% -57.13% -219.29%
Net Nonoperating Expense Percent (NNEP)
-25.09% 0.00% 1.97% -58.29% -48.64% 10.82% -106.15% -4.39% -7.01% -16.32% -39.05%
Return On Investment Capital (ROIC_SIMPLE)
-32.90% - -50.13% -186.91% -75.32% -27.00% -45.39% -21.74% -19.56% -17.72% -40.65%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 14.88% 14.86% 14.90% 14.85% 9.39% 15.27%
SG&A Expenses to Revenue
0.00% 102.15% 0.00% 0.00% 0.00% 967.20% 186.87% 139.42% 119.43% 68.39% 110.30%
R&D to Revenue
0.00% 180.62% 0.00% 0.00% 0.00% 1,159.85% 257.86% 180.62% 204.69% 103.14% 286.55%
Operating Expenses to Revenue
0.00% 282.77% 0.00% 0.00% 0.00% 2,133.04% 447.31% 321.64% 325.62% 172.23% 398.01%
Earnings before Interest and Taxes (EBIT)
-28 -8.10 -24 -70 -51 -27 -99 -34 -38 -35 -75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-29 -8.09 -23 -70 -51 -26 -99 -33 -37 -34 -75
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
15.83 0.00 10.88 0.00 0.00 6.32 0.00 9.01 5.69 6.72 72.17
Price to Tangible Book Value (P/TBV)
15.83 0.00 10.88 0.00 0.00 11.17 0.00 12.64 7.09 9.84 0.00
Price to Revenue (P/Rev)
0.00 7.55 12.03 23.01 31.05 106.71 40.62 16.68 9.39 3.84 7.27
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 6.90 18.20 26.64 66.04 36.18 12.51 7.32 3.18 6.74
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.02 0.00 1.26 -1.41 -2.27 2.15 -5.04 1.33 0.97 1.58 11.82
Long-Term Debt to Equity
0.88 0.00 0.95 -1.41 -2.20 2.06 -5.03 1.33 0.89 1.48 11.19
Financial Leverage
-1.20 0.00 -1.45 -2.93 -11.49 -2.41 -7.90 -6.25 -2.99 -1.68 20.83
Leverage Ratio
2.41 0.00 2.22 5.06 31.34 5.44 18.17 12.29 7.29 4.68 -74.93
Compound Leverage Factor
0.00 0.00 0.00 9.41 31.99 0.00 0.00 76.63 7.11 4.58 -74.38
Debt to Total Capital
50.51% 0.00% 55.79% 344.21% 179.00% 68.22% 124.73% 57.16% 49.11% 61.31% 92.20%
Short-Term Debt to Total Capital
6.74% 0.00% 13.73% 0.00% 4.90% 2.76% 0.30% 0.00% 3.61% 4.21% 4.94%
Long-Term Debt to Total Capital
43.77% 0.00% 42.06% 344.21% 174.11% 65.46% 124.43% 57.16% 45.50% 57.10% 87.27%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
26.17% 0.00% 29.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
23.32% 0.00% 15.18% -244.21% -79.00% 31.78% -24.73% 42.84% 50.89% 38.69% 7.80%
Debt to EBITDA
-0.41 0.00 -0.46 -0.31 -0.48 -0.45 -0.32 -0.36 -0.40 -0.39 -0.66
Net Debt to EBITDA
0.43 0.00 0.81 0.37 0.29 0.51 0.24 0.61 0.52 0.28 0.30
Long-Term Debt to EBITDA
-0.36 0.00 -0.34 -0.31 -0.47 -0.43 -0.32 -0.36 -0.37 -0.36 -0.63
Debt to NOPAT
-0.58 0.00 -0.51 -0.51 -0.80 -0.71 -0.70 -0.64 -0.66 -0.71 -0.88
Net Debt to NOPAT
0.60 0.00 0.90 0.60 0.48 0.79 0.53 1.08 0.86 0.51 0.39
Long-Term Debt to NOPAT
-0.50 0.00 -0.38 -0.51 -0.78 -0.68 -0.70 -0.64 -0.61 -0.66 -0.83
Altman Z-Score
-8.84 0.00 -8.85 -13.54 -9.97 -6.20 -8.41 -4.57 -5.08 -6.65 -6.14
Noncontrolling Interest Sharing Ratio
44.93% 0.00% 30.99% 42.62% 279.25% 0.00% 126.75% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.28 0.00 3.23 3.07 3.50 3.46 2.58 3.09 3.04 2.25 1.93
Quick Ratio
3.08 0.00 3.03 2.87 3.30 3.30 2.42 2.96 2.87 2.11 1.77
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-33 -33 -6.83 36 43 20 6.11 -35 -87 -66 -84
Operating Cash Flow to CapEx
-134,795.24% -393,857.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-29.45 -28.79 -5.95 31.73 21.35 95.39 19.16 -83.85 -227.64 -184.34 -396.54
Operating Cash Flow to Interest Expense
-25.05 -24.23 -20.73 -21.90 -19.17 -154.07 -113.53 -72.18 -136.43 -121.97 -158.46
Operating Cash Flow Less CapEx to Interest Expense
-25.07 -24.23 -20.73 -21.90 -19.17 -154.07 -113.53 -72.18 -136.43 -121.97 -158.46
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.07 0.08 0.08 0.01 0.09 0.18 0.28 0.43 0.49
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 1.03 0.00 0.00 0.00 5.66 12.09
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.27 0.00 0.00 0.00 6.07 6.33
Fixed Asset Turnover
0.00 0.00 270.27 289.86 294.12 101.76 453.53 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.04 0.28 0.56 0.88 0.83 0.85
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 354.58 0.00 0.00 0.00 64.53 30.19
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 1,340.63 0.00 0.00 0.00 60.14 57.62
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 9,236.34 1,315.14 653.59 415.92 439.48 428.96
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 -7,541.13 -1,315.14 -653.59 -415.92 -314.81 -341.15
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-2.76 0.00 -40 -77 -77 -51 -75 -71 -21 -7.39 -44
Invested Capital Turnover
0.00 0.00 -0.33 -0.21 -0.25 -0.08 -0.23 -0.42 -1.01 -3.01 -1.69
Increase / (Decrease) in Invested Capital
14 20 -19 -58 -74 -51 -35 5.77 56 43 31
Enterprise Value (EV)
277 0.00 69 182 266 141 484 387 363 279 676
Market Capitalization
298 75 120 230 310 228 543 516 466 336 729
Book Value per Share
$0.75 $0.00 $0.27 ($0.65) ($0.63) $0.66 ($0.25) $0.86 $0.93 $0.57 $0.11
Tangible Book Value per Share
$0.75 $0.00 $0.27 ($0.65) ($0.63) $0.37 ($0.52) $0.61 $0.75 $0.39 ($0.06)
Total Capital
81 0.00 73 12 41 113 63 134 161 129 130
Total Debt
41 0.00 41 41 73 77 78 76 79 79 119
Total Long-Term Debt
35 0.00 31 41 71 74 78 76 73 74 113
Net Debt
-43 0.00 -73 -48 -44 -87 -59 -129 -103 -57 -53
Capital Expenditures (CapEx)
0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-8.62 0.00 -20 -25 -26 -37 -43 -54 -40 -33 -70
Debt-free Net Working Capital (DFNWC)
75 0.00 93 64 91 127 95 151 142 103 102
Net Working Capital (NWC)
69 0.00 83 64 89 124 94 151 136 98 96
Net Nonoperating Expense (NNE)
14 -4.54 -1.95 42 21 -4.70 70 3.88 5.16 12 22
Net Nonoperating Obligations (NNO)
-43 0.00 -73 -48 -44 -87 -59 -129 -103 -57 -54
Total Depreciation and Amortization (D&A)
-0.41 0.01 0.21 0.21 0.04 0.13 0.29 0.30 0.16 0.16 0.28
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% -198.84% -248.30% -264.79% -1,744.31% -322.70% -174.18% -80.31% -37.57% -70.15%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 932.91% 639.88% 910.90% 5,945.06% 706.57% 488.92% 286.08% 118.21% 102.14%
Net Working Capital to Revenue
0.00% 0.00% 832.88% 639.88% 890.80% 5,798.41% 705.16% 488.92% 274.40% 112.00% 95.76%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.60) ($1.81) ($0.96) ($0.39) ($1.35) ($0.32) ($0.37) ($0.35) ($0.74)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 40.26M 35.71M 54.17M 66.14M 73.16M 69.31M 98.29M 100.12M 101.24M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.60) ($1.81) ($0.96) ($0.62) ($1.35) ($0.09) ($0.46) ($0.35) ($0.74)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 40.26M 35.71M 54.17M 74.04M 73.16M 69.31M 99.15M 100.12M 101.24M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 ($1.81) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 44.51M 51.49M 54.95M 61.55M 66.78M 87.84M 87.87M 90.56M 126.01M
Normalized Net Operating Profit after Tax (NOPAT)
-20 -13 -26 -22 -31 -31 -29 -29 -31 -23 -53
Normalized NOPAT Margin
0.00% -127.94% 0.00% 0.00% 0.00% -1,433.54% -253.52% -165.57% -168.32% -57.13% -219.29%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,194.59% -195.98% -84.48% -311.19%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-24.86 -7.12 -20.60 -61.26 -25.28 -125.21 -311.54 -80.98 -98.18 -96.13 -355.08
NOPAT to Interest Expense
-17.38 -11.24 -22.58 -19.30 -15.32 -144.50 -89.34 -69.96 -82.27 -63.60 -248.38
EBIT Less CapEx to Interest Expense
-24.88 -7.12 -20.60 -61.26 -25.28 -125.21 -311.54 -80.98 -98.18 -96.13 -355.08
NOPAT Less CapEx to Interest Expense
-17.40 -11.25 -22.58 -19.30 -15.32 -144.50 -89.34 -69.96 -82.27 -63.60 -248.38
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Verastem’s Q2 2026 results show a meaningful improvement in commercial revenue, but the company remains firmly unprofitable and cash-flow negative. Revenue increased to $40.1 million from $2.1 million in Q2 2025 and $18.7 million in Q1 2026. Gross profit rose to $36.3 million, representing an approximately 91% gross margin.

Despite the stronger revenue base, operating expenses remained substantial. Research and development expense increased to $41.3 million in Q2 2026 from $24.8 million in Q2 2025, while selling, general and administrative expense rose to $27.4 million. The operating loss improved year over year to $32.7 million from $43.8 million, but Verastem still reported a net loss of $34.7 million, or $0.35 per diluted share.

Liquidity has weakened as the company continues to fund operations. Cash and equivalents declined to $136.4 million at June 30, 2026, from $165.6 million at March 31 and $164.3 million a year earlier. Operating cash burn was $43.9 million in Q2, following $52.1 million in Q1. At the recent quarterly burn rate, the cash balance provides only several quarters of operating capacity before additional financing may be required, although the estimate could change materially with revenue growth, expense reductions or financing activity.

  • Revenue is scaling rapidly: Q2 2026 revenue of $40.1 million was nearly 19 times the Q2 2025 level and more than doubled sequentially from Q1 2026.
  • Strong gross margins: Gross profit of $36.3 million equated to approximately 91% of revenue, providing a potentially favorable foundation for future operating leverage if revenue continues to expand.
  • Operating losses improved year over year: The Q2 operating loss narrowed to $32.7 million from $43.8 million in Q2 2025, despite higher research and development spending.
  • Balance-sheet equity recovered: Shareholders’ equity was positive at $50.0 million in Q2 2026, compared with negative equity of $15.5 million in Q3 2025 and negative equity of $32.4 million in Q1 2025.
  • Current liquidity remains adequate in the near term: Current assets of $176.2 million exceeded current liabilities of $78.1 million, producing a current ratio of approximately 2.3. However, most current assets were cash, and the company continues to consume cash.
  • Financing has supported operations: Verastem raised substantial capital through equity and other financing activities during 2025 and early 2026, but future financing needs will depend on whether commercial revenue can offset research and operating costs.
  • Cash burn remains significant: Operating cash flow was negative $43.9 million in Q2 2026 and negative $52.1 million in Q1, while cash fell by $29.2 million during Q2.
  • Net losses remain large: Verastem has reported recurring quarterly losses throughout the period presented, with a Q2 2026 net loss of $34.7 million and accumulated retained earnings of negative $1.24 billion.
  • Research spending is accelerating: R&D expense rose approximately 67% year over year to $41.3 million, keeping total operating expenses well above gross profit.
  • Shareholder dilution is a concern: Weighted-average basic shares outstanding increased to 100.1 million in Q2 2026 from 66.1 million in Q2 2025, reflecting the company’s reliance on equity-related financing and reducing per-share participation in future gains.

Overall, Verastem’s financial profile is improving on the revenue and gross-margin lines, but the investment case still depends on sustained commercial growth, eventual operating leverage and access to additional capital. Investors should also consider that several historical figures were restated or classified differently in the supplied data, which can make direct period-to-period comparisons less precise.

11/16/26 10:22 AM ETAI Generated. May Contain Errors.

Verastem Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Verastem's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Verastem's net income appears to be on a downward trend, with a most recent value of -$209.47 million in 2025, falling from -$57.87 million in 2015. The previous period was -$130.64 million in 2024. Check out Verastem's forecast to explore projected trends and price targets.

Verastem's total operating income in 2025 was -$170.13 million, based on the following breakdown:
  • Total Gross Profit: $26.31 million
  • Total Operating Expenses: $196.44 million

Over the last 10 years, Verastem's total revenue changed from $0.00 in 2015 to $30.91 million in 2025, a change of 3,091,400,000.0%.

In the past 12 quarters, Verastem's cash and equivalents has ranged from $83.37 million in Q1 2024 to $172.80 million in Q3 2026, and is currently $172.80 million as of their latest financial filing in Q3 2026.

Verastem had total debt of $76.33 million at the end of 2025, a 87.4% increase from 2024, and none in 2015.

Over the last 10 years, Verastem's book value per share changed from 2.77 in 2015 to 0.86 in 2025, a change of -69.1%.



Financial statements for NASDAQ:VSTM last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners